Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Influenza

  Free Subscription


Articles published in Biochem Biophys Res Commun

Retrieve available abstracts of 93 articles:
HTML format



Single Articles


    May 2021
  1. PADHI AK, Tripathi T
    Targeted design of drug binding sites in the main protease of SARS-CoV-2 reveals potential signatures of adaptation.
    Biochem Biophys Res Commun. 2021;555:147-153.
    PubMed     Abstract available


  2. VANDYCK K, Abdelnabi R, Gupta K, Jochmans D, et al
    ALG-097111, a potent and selective SARS-CoV-2 3-chymotrypsin-like cysteine protease inhibitor exhibits in vivo efficacy in a Syrian Hamster model.
    Biochem Biophys Res Commun. 2021;555:134-139.
    PubMed     Abstract available


  3. CAO B, Kang T
    Nonlinear adaptive control of COVID-19 with media campaigns and treatment.
    Biochem Biophys Res Commun. 2021;555:202-209.
    PubMed     Abstract available


  4. IDREES D, Kumar V
    SARS-CoV-2 spike protein interactions with amyloidogenic proteins: Potential clues to neurodegeneration.
    Biochem Biophys Res Commun. 2021;554:94-98.
    PubMed     Abstract available


  5. KRUSE RL, Huang Y, Smetana H, Gehrie EA, et al
    A rapid, point-of-care red blood cell agglutination assay detecting antibodies against SARS-CoV-2.
    Biochem Biophys Res Commun. 2021;553:165-171.
    PubMed     Abstract available


  6. ZHANG Y, Niu G, Flisikowska T, Schnieke A, et al
    A tissue- and gender-specific regulation of the SARS-CoV-2 receptor ACE2 by p53 in pigs.
    Biochem Biophys Res Commun. 2021;553:25-29.
    PubMed     Abstract available


    April 2021
  7. PEREIRA F
    SARS-CoV-2 variants combining spike mutations and the absence of ORF8 may be more transmissible and require close monitoring.
    Biochem Biophys Res Commun. 2021;550:8-14.
    PubMed     Abstract available


    March 2021
  8. SHIBUYA M, Tamiya S, Kawai A, Yoshioka Y, et al
    Nasal-subcutaneous prime-boost regimen for inactivated whole-virus influenza vaccine efficiently protects mice against both upper and lower respiratory tract infections.
    Biochem Biophys Res Commun. 2021;554:166-172.
    PubMed     Abstract available


  9. SAKURAI Y, Ngwe Tun MM, Kurosaki Y, Sakura T, et al
    5-amino levulinic acid inhibits SARS-CoV-2 infection in vitro.
    Biochem Biophys Res Commun. 2021;545:203-207.
    PubMed     Abstract available


  10. ADAMI EA, Chavez Rico SL, Akamatsu MA, Miyaki C, et al
    H7N9 pandemic preparedness: A large-scale production of a split inactivated vaccine.
    Biochem Biophys Res Commun. 2021;545:145-149.
    PubMed     Abstract available


  11. SMITS VAJ, Hernandez-Carralero E, Paz-Cabrera MC, Cabrera E, et al
    The Nucleocapsid protein triggers the main humoral immune response in COVID-19 patients.
    Biochem Biophys Res Commun. 2021;543:45-49.
    PubMed     Abstract available


    January 2021
  12. INTAWONG K, Olson D, Chariyalertsak S
    Application technology to fight the COVID-19 pandemic: Lessons learned in Thailand.
    Biochem Biophys Res Commun. 2021;538:231-237.
    PubMed     Abstract available


  13. SANTORO MG, Carafoli E
    Remdesivir: From Ebola to COVID-19.
    Biochem Biophys Res Commun. 2021;538:145-150.
    PubMed     Abstract available


  14. MOORE KM, Suthar MS
    Comprehensive analysis of COVID-19 during pregnancy.
    Biochem Biophys Res Commun. 2021;538:180-186.
    PubMed     Abstract available


  15. VIANELLO C, Strozzi F, Mocellin P, Cimetta E, et al
    A perspective on early detection systems models for COVID-19 spreading.
    Biochem Biophys Res Commun. 2021;538:244-252.
    PubMed     Abstract available


  16. PASETTO D, Lemaitre JC, Bertuzzo E, Gatto M, et al
    Range of reproduction number estimates for COVID-19 spread.
    Biochem Biophys Res Commun. 2021;538:253-258.
    PubMed     Abstract available


  17. JANS DA, Wagstaff KM
    The broad spectrum host-directed agent ivermectin as an antiviral for SARS-CoV-2 ?
    Biochem Biophys Res Commun. 2021;538:163-172.
    PubMed     Abstract available


  18. REZNIKOV LR, Norris MH, Vashisht R, Bluhm AP, et al
    Identification of antiviral antihistamines for COVID-19 repurposing.
    Biochem Biophys Res Commun. 2021;538:173-179.
    PubMed     Abstract available


  19. SANTOPOLO S, Riccio A, Santoro MG
    The biogenesis of SARS-CoV-2 spike glycoprotein: multiple targets for host-directed antiviral therapy.
    Biochem Biophys Res Commun. 2021;538:80-87.
    PubMed     Abstract available


  20. BACCA E, Digaetano M, Meschiari M, Franceschini E, et al
    Immunomodulation for the management of severe SARS-CoV2 infections. State of the art and review of the literature.
    Biochem Biophys Res Commun. 2021;538:151-155.
    PubMed     Abstract available


  21. WATASHI K
    Identifying and repurposing antiviral drugs against severe acute respiratory syndrome coronavirus 2 with in silico and in vitro approaches.
    Biochem Biophys Res Commun. 2021;538:137-144.
    PubMed     Abstract available


  22. WALSH MA, Grimes JM, Stuart DI
    Diamond Light Source: contributions to SARS-CoV-2 biology and therapeutics.
    Biochem Biophys Res Commun. 2021;538:40-46.
    PubMed     Abstract available


  23. MOURIER T, Sadykov M, Carr MJ, Gonzalez G, et al
    Host-directed editing of the SARS-CoV-2 genome.
    Biochem Biophys Res Commun. 2021;538:35-39.
    PubMed     Abstract available


  24. CHENG HY, Huang AS
    Proactive and blended approach for COVID-19 control in Taiwan.
    Biochem Biophys Res Commun. 2021;538:238-243.
    PubMed     Abstract available


  25. KALFAOGLU B, Almeida-Santos J, Tye CA, Satou Y, et al
    T-cell dysregulation in COVID-19.
    Biochem Biophys Res Commun. 2021;538:204-210.
    PubMed     Abstract available


  26. JACKSON CB, Zhang L, Farzan M, Choe H, et al
    Functional importance of the D614G mutation in the SARS-CoV-2 spike protein.
    Biochem Biophys Res Commun. 2021;538:108-115.
    PubMed     Abstract available


  27. KENNY G, Mallon PW
    COVID19- clinical presentation and therapeutic considerations.
    Biochem Biophys Res Commun. 2021;538:125-131.
    PubMed     Abstract available


  28. SCHENKELBERG T
    Vaccine-induced protection in aging adults and pandemic response.
    Biochem Biophys Res Commun. 2021;538:218-220.
    PubMed    


  29. PLATTO S, Wang Y, Zhou J, Carafoli E, et al
    History of the COVID-19 pandemic: Origin, explosion, worldwide spreading.
    Biochem Biophys Res Commun. 2021;538:14-23.
    PubMed     Abstract available


  30. GROVES DC, Rowland-Jones SL, Angyal A
    The D614G mutations in the SARS-CoV-2 spike protein: Implications for viral infectivity, disease severity and vaccine design.
    Biochem Biophys Res Commun. 2021;538:104-107.
    PubMed     Abstract available


  31. GIOVANETTI M, Benedetti F, Campisi G, Ciccozzi A, et al
    Evolution patterns of SARS-CoV-2: Snapshot on its genome variants.
    Biochem Biophys Res Commun. 2021;538:88-91.
    PubMed     Abstract available


  32. DIPIAZZA AT, Graham BS, Ruckwardt TJ
    T cell immunity to SARS-CoV-2 following natural infection and vaccination.
    Biochem Biophys Res Commun. 2021;538:211-217.
    PubMed     Abstract available


  33. CARRILLO J, Izquierdo-Useros N, Avila-Nieto C, Pradenas E, et al
    Humoral immune responses and neutralizing antibodies against SARS-CoV-2; implications in pathogenesis and protective immunity.
    Biochem Biophys Res Commun. 2021;538:187-191.
    PubMed     Abstract available


  34. SARVER DC, Wong GW
    Obesity alters Ace2 and Tmprss2 expression in lung, trachea, and esophagus in a sex-dependent manner: Implications for COVID-19.
    Biochem Biophys Res Commun. 2021;538:92-96.
    PubMed     Abstract available


  35. BAXTER C, Abdool Karim Q, Abdool Karim SS
    Identifying SARS-CoV-2 infections in South Africa: Balancing public health imperatives with saving lives.
    Biochem Biophys Res Commun. 2021;538:221-225.
    PubMed    


  36. LAI CKC, Lam W
    Laboratory testing for the diagnosis of COVID-19.
    Biochem Biophys Res Commun. 2021;538:226-230.
    PubMed     Abstract available


  37. FANTINI J, Chahinian H, Yahi N
    Leveraging coronavirus binding to gangliosides for innovative vaccine and therapeutic strategies against COVID-19.
    Biochem Biophys Res Commun. 2021;538:132-136.
    PubMed     Abstract available


  38. PLATTO S, Zhou J, Wang Y, Wang H, et al
    Biodiversity loss and COVID-19 pandemic: The role of bats in the origin and the spreading of the disease.
    Biochem Biophys Res Commun. 2021;538:2-13.
    PubMed     Abstract available


  39. ZINZULA L, Basquin J, Bohn S, Beck F, et al
    High-resolution structure and biophysical characterization of the nucleocapsid phosphoprotein dimerization domain from the Covid-19 severe acute respiratory syndrome coronavirus 2.
    Biochem Biophys Res Commun. 2021;538:54-62.
    PubMed     Abstract available


  40. CARAFOLI E
    Chloroquine and hydroxychloroquine in the prophylaxis and therapy of COVID-19 infection.
    Biochem Biophys Res Commun. 2021;538:156-162.
    PubMed     Abstract available


  41. JIANG Y, Yin W, Xu HE
    RNA-dependent RNA polymerase: Structure, mechanism, and drug discovery for COVID-19.
    Biochem Biophys Res Commun. 2021;538:47-53.
    PubMed     Abstract available



  42. Editorial.
    Biochem Biophys Res Commun. 2021;538:1.
    PubMed    


  43. CHAKRABORTY S
    Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity.
    Biochem Biophys Res Commun. 2021;538:97-103.
    PubMed     Abstract available


  44. GU L, Zhou Y, Wang G, Deng H, et al
    Spatial learning and memory impaired after infection of non-neurotropic influenza virus in BALB/c male mice.
    Biochem Biophys Res Commun. 2021;540:29-36.
    PubMed     Abstract available


  45. SHARMA A, Preece B, Swann H, Fan X, et al
    Structural stability of SARS-CoV-2 virus like particles degrades with temperature.
    Biochem Biophys Res Commun. 2021;534:343-346.
    PubMed     Abstract available


  46. INTAWONG K, Olson D, Chariyalertsak S
    Application technology to fight the COVID-19 pandemic: Lessons learned in Thailand.
    Biochem Biophys Res Commun. 2021;534:830-836.
    PubMed     Abstract available


  47. LIMA MA, Skidmore M, Khanim F, Richardson A, et al
    Development of a nano-luciferase based assay to measure the binding of SARS-CoV-2 spike receptor binding domain to ACE-2.
    Biochem Biophys Res Commun. 2021;534:485-490.
    PubMed     Abstract available


  48. CHAKRABORTY S
    Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity.
    Biochem Biophys Res Commun. 2021;534:374-380.
    PubMed     Abstract available


    November 2020
  49. JEREMIAH SS, Miyakawa K, Morita T, Yamaoka Y, et al
    Potent antiviral effect of silver nanoparticles on SARS-CoV-2.
    Biochem Biophys Res Commun. 2020;533:195-200.
    PubMed     Abstract available


    October 2020
  50. TUNG HYL, Limtung P
    Mutations in the phosphorylation sites of SARS-CoV-2 encoded nucleocapsid protein and structure model of sequestration by protein 14-3-3.
    Biochem Biophys Res Commun. 2020;532:134-138.
    PubMed     Abstract available


    September 2020
  51. CHEN P, Zeng Z, Du H
    Establishment and validation of a drug-target microarray for SARS-CoV-2.
    Biochem Biophys Res Commun. 2020;530:4-9.
    PubMed     Abstract available


  52. SINGH TOMAR PP, Arkin IT
    SARS-CoV-2 E protein is a potential ion channel that can be inhibited by Gliclazide and Memantine.
    Biochem Biophys Res Commun. 2020;530:10-14.
    PubMed     Abstract available


  53. TAKEDA Y, Uchiumi H, Matsuda S, Ogawa H, et al
    Acidic electrolyzed water potently inactivates SARS-CoV-2 depending on the amount of free available chlorine contacting with the virus.
    Biochem Biophys Res Commun. 2020;530:1-3.
    PubMed     Abstract available


  54. XU H, Qian J, Song Y, Ming D, et al
    The adaptability of H9N2 avian influenza A virus to humans: A comparative docking simulation study.
    Biochem Biophys Res Commun. 2020;529:963-969.
    PubMed     Abstract available


    August 2020
  55. ZHANG H, Tu J, Cao C, Yang T, et al
    Proteasome activator PA28gamma-dependent degradation of coronavirus disease (COVID-19) nucleocapsid protein.
    Biochem Biophys Res Commun. 2020;529:251-256.
    PubMed     Abstract available


    July 2020
  56. CHOI JY, Lee HK, Park JH, Cho SJ, et al
    Altered COVID-19 receptor ACE2 expression in a higher risk group for cerebrovascular disease and ischemic stroke.
    Biochem Biophys Res Commun. 2020;528:413-419.
    PubMed     Abstract available


  57. BONGINI P, Trezza A, Bianchini M, Spiga O, et al
    A possible strategy to fight COVID-19: Interfering with spike glycoprotein trimerization.
    Biochem Biophys Res Commun. 2020;528:35-38.
    PubMed     Abstract available


  58. WAKIDA H, Kawata K, Yamaji Y, Hattori E, et al
    Stability of RNA sequences derived from the coronavirus genome in human cells.
    Biochem Biophys Res Commun. 2020;527:993-999.
    PubMed     Abstract available


    June 2020
  59. ZENG W, Liu G, Ma H, Zhao D, et al
    Biochemical characterization of SARS-CoV-2 nucleocapsid protein.
    Biochem Biophys Res Commun. 2020;527:618-623.
    PubMed     Abstract available


  60. OTHMAN H, Bouslama Z, Brandenburg JT, da Rocha J, et al
    Interaction of the spike protein RBD from SARS-CoV-2 with ACE2: Similarity with SARS-CoV, hot-spot analysis and effect of the receptor polymorphism.
    Biochem Biophys Res Commun. 2020;527:702-708.
    PubMed     Abstract available


  61. LI Y, Li H, Zhou L
    EZH2-mediated H3K27me3 inhibits ACE2 expression.
    Biochem Biophys Res Commun. 2020;526:947-952.
    PubMed     Abstract available


    May 2020
  62. LUAN J, Lu Y, Jin X, Zhang L, et al
    Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection.
    Biochem Biophys Res Commun. 2020;526:165-169.
    PubMed     Abstract available


  63. QI F, Qian S, Zhang S, Zhang Z, et al
    Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses.
    Biochem Biophys Res Commun. 2020;526:135-140.
    PubMed     Abstract available


    April 2020
  64. HUANG Q, Zhong Y, Li J, Ye Y, et al
    Kinase inhibitor roscovitine as a PB2 cap-binding inhibitor against influenza a virus replication.
    Biochem Biophys Res Commun. 2020 Apr 13. pii: S0006-291X(20)30756.
    PubMed     Abstract available


    February 2020
  65. MORRIS AK, Wang Z, Ivey AL, Xie Y, et al
    Cellular mRNA export factor UAP56 recognizes nucleic acid binding site of influenza virus NP protein.
    Biochem Biophys Res Commun. 2020 Feb 19. pii: S0006-291X(20)30327.
    PubMed     Abstract available


    December 2019
  66. CHEN F, Yang L, Huang Y, Chen Y, et al
    Isocorilagin, isolated from Canarium album (Lour.) Raeusch, as a potent neuraminidase inhibitor against influenza A virus.
    Biochem Biophys Res Commun. 2019 Dec 13. pii: S0006-291X(19)32363.
    PubMed     Abstract available


    October 2019
  67. NISHIOKA K, Daidoji T, Nakaya T
    Demethylation around the transcriptional start site of the IFN-beta gene induces IFN-beta production and protection against influenza virus infection.
    Biochem Biophys Res Commun. 2019 Oct 5. pii: S0006-291X(19)31874.
    PubMed     Abstract available


    August 2019
  68. YAN L, Wang H, Sun L, Liu Y, et al
    An epitope on the stem region of hemagglutinin of H1N1 influenza A virus recognized by neutralizing monoclonal antibody.
    Biochem Biophys Res Commun. 2019 Aug 14. pii: S0006-291X(19)31572.
    PubMed     Abstract available


  69. SHEN Q, Cho JH
    The structure and conformational plasticity of the nonstructural protein 1 of the 1918 influenza A virus.
    Biochem Biophys Res Commun. 2019 Aug 14. pii: S0006-291X(19)31538.
    PubMed     Abstract available


    July 2019
  70. JUNG Y, Kong B, Moon S, Yu SH, et al
    Envelope-deforming antiviral peptide derived from influenza virus M2 protein.
    Biochem Biophys Res Commun. 2019 Jul 30. pii: S0006-291X(19)31442.
    PubMed     Abstract available


    June 2019
  71. CHEN Q, Huang X, Wei R, Zhang L, et al
    Characterization of influenza virus PR8 strain cultured in embryonated eggs by cryo-electron tomography.
    Biochem Biophys Res Commun. 2019 Jun 10. pii: S0006-291X(19)31059.
    PubMed     Abstract available


    April 2019
  72. NAMKOONG H, Ishii M, Fujii H, Asami T, et al
    Obesity worsens the outcome of influenza virus infection associated with impaired type I interferon induction in mice.
    Biochem Biophys Res Commun. 2019 Apr 6. pii: S0006-291X(19)30618.
    PubMed     Abstract available


  73. SUN L, Li H, Sun J, Guo C, et al
    Antibodies against H1N1 influenza virus hemagglutinin cross-react with prohibitin.
    Biochem Biophys Res Commun. 2019 Apr 6. pii: S0006-291X(19)30595.
    PubMed     Abstract available


    March 2019
  74. ZHU Y, Shao Y, Qu X, Guo J, et al
    Sodium ferulate protects against influenza virus infection by activation of the TLR7/9-MyD88-IRF7 signaling pathway and inhibition of the NF-kappaB signaling pathway.
    Biochem Biophys Res Commun. 2019 Mar 27. pii: S0006-291X(19)30502.
    PubMed     Abstract available


  75. YAMAMOTO Y, Tamiya S, Shibuya M, Nakase I, et al
    Peptides with the multibasic cleavage site of the hemagglutinin from highly pathogenic influenza viruses act as cell-penetrating via binding to heparan sulfate and neuropilins.
    Biochem Biophys Res Commun. 2019 Mar 20. pii: S0006-291X(19)30451.
    PubMed     Abstract available


    December 2018
  76. YI E, Oh J, Kang HR, Song MJ, et al
    BST2 inhibits infection of influenza A virus by promoting apoptosis of infected cells.
    Biochem Biophys Res Commun. 2018 Dec 26. pii: S0006-291X(18)32759.
    PubMed     Abstract available


    November 2018
  77. TAKEDA Y, Takaki H, Fukui-Miyazaki A, Yoshida S, et al
    Vaccine adjuvant ARNAX promotes mucosal IgA production in influenza HA vaccination.
    Biochem Biophys Res Commun. 2018 Nov 4. pii: S0006-291X(18)32350.
    PubMed     Abstract available


    August 2018
  78. WANG B, Zhang Y, Jiang W, Zhu L, et al
    GALNT3 inhibits NF-kappaB signaling during influenza A virus infection.
    Biochem Biophys Res Commun. 2018 Aug 9. pii: S0006-291X(18)31740.
    PubMed     Abstract available


    July 2018
  79. WANG J, Liu M, Ding N, Li Y, et al
    Vaccine based on antibody-dependent cell-mediated cytotoxicity epitope on the H1N1 influenza virus increases mortality in vaccinated mice.
    Biochem Biophys Res Commun. 2018 Jul 28. pii: S0006-291X(18)31633.
    PubMed     Abstract available


    June 2018
  80. TANG Z, Zang N, Fu Y, Ye Z, et al
    HMGB1 mediates HAdV-7 infection-induced pulmonary inflammation in mice.
    Biochem Biophys Res Commun. 2018;501:1-8.
    PubMed     Abstract available


    May 2018
  81. MURALIDHARAN A, Gravel C, Duran A, Larocque L, et al
    Identification of immunodominant CD8 epitope in the stalk domain of influenza B viral hemagglutinin.
    Biochem Biophys Res Commun. 2018 May 21. pii: S0006-291X(18)31217.
    PubMed     Abstract available


    March 2018
  82. JUNG KI, Pyo CW, Choi SY
    Influenza A virus-induced autophagy contributes to enhancement of virus infectivity by SOD1 downregulation in alveolar epithelial cells.
    Biochem Biophys Res Commun. 2018 Mar 16. pii: S0006-291X(18)30581.
    PubMed     Abstract available


  83. TAKAHASHI H, Nagata S, Odagiri T, Kageyama T, et al
    Establishment of the cross-clade antigen detection system for H5 subtype influenza viruses using peptide monoclonal antibodies specific for influenza virus H5 hemagglutinin.
    Biochem Biophys Res Commun. 2018 Mar 7. pii: S0006-291X(18)30532.
    PubMed     Abstract available


    February 2018
  84. SHINDE A, Luo J, Bharathi SS, Shi H, et al
    Increased mortality from influenza infection in long-chain acyl-CoA dehydrogenase knockout mice.
    Biochem Biophys Res Commun. 2018 Feb 16. pii: S0006-291X(18)30366.
    PubMed     Abstract available


    October 2017
  85. CHO J, Yi H, Jang EY, Lee MS, et al
    Mycophenolic mofetil, an alternative antiviral and immunomodulator for the highly pathogenic avian influenza H5N1 virus infection.
    Biochem Biophys Res Commun. 2017 Oct 7. pii: S0006-291X(17)32007.
    PubMed     Abstract available


    September 2017
  86. NAKASHIMA A, Suzuki K, Asayama Y, Konno M, et al
    Oral administration of Euglena gracilis Z and its carbohydrate storage substance provides survival protection against influenza virus infection in mice.
    Biochem Biophys Res Commun. 2017 Sep 30. pii: S0006-291X(17)31957.
    PubMed     Abstract available


  87. KIM YJ, Ko EJ, Kim MC, Lee YN, et al
    Roles of antibodies to influenza A virus hemagglutinin, neuraminidase, and M2e in conferring cross protection.
    Biochem Biophys Res Commun. 2017 Sep 5. pii: S0006-291X(17)31771.
    PubMed     Abstract available


  88. MA JH, Song SH, Guo M, Zhou J, et al
    Long-term exposure to PM2.5 lowers influenza virus resistance via down-regulating pulmonary macrophage Kdm6a and mediates histones modification in IL-6 and IFN-beta promoter regions.
    Biochem Biophys Res Commun. 2017 Sep 5. pii: S0006-291X(17)31772.
    PubMed     Abstract available


    August 2017
  89. PANG LL, Yuan XH, Shao CS, Li MZ, et al
    The suppression of innate immune response by human rhinovirus C.
    Biochem Biophys Res Commun. 2017;490:22-28.
    PubMed     Abstract available


    May 2017
  90. YAMASHITA N, Yashiro M, Ogawa H, Namba H, et al
    Metabolic pathway catalyzed by Vanin-1 pantetheinase plays a suppressive role in influenza virus replication in human alveolar epithelial A549 cells.
    Biochem Biophys Res Commun. 2017 May 30. pii: S0006-291X(17)31081.
    PubMed     Abstract available


    December 2016
  91. FENG W, Sun X, Shi N, Zhang M, et al
    Influenza a virus NS1 protein induced A20 contributes to viral replication by suppressing interferon-induced antiviral response.
    Biochem Biophys Res Commun. 2016 Dec 1. pii: S0006-291X(16)32040.
    PubMed     Abstract available


    September 2016
  92. MORI T, Nakamura K, Masaoka K, Fujita Y, et al
    Cleavage of influenza RNA by using a human PUF-based artificial RNA-binding protein-staphylococcal nuclease hybrid.
    Biochem Biophys Res Commun. 2016 Sep 28. pii: S0006-291X(16)31616.
    PubMed     Abstract available


  93. PARK S, Lee I, Kim JI, Bae JY, et al
    Effects of HA and NA glycosylation pattern changes on the transmission of avian influenza A(H7N9) virus in guinea pigs.
    Biochem Biophys Res Commun. 2016 Sep 6. pii: S0006-291X(16)31471.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: